Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.

Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.

Item
http://www.wikidata.org/entity/Q33753017
A critical review of the fluoroquinolones: focus on respiratory infectionsLevofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureusIn vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisSpectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineLevofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.The new fluoroquinolones: A critical reviewDrug disposition in pathophysiological conditions.Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesComparative pharmacokinetics of levofloxacin in healthy volunteers and in patients suffering from typhoid Fever.A Review of New Fluoroquinolones
P2860

Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection.

Item
http://www.wikidata.org/entity/Q33753017
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@ast
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@en
type
label
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@ast
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@en
prefLabel
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@ast
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Pharmacokinetics and safety of ...... unodeficiency virus infection.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932